These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38880251)

  • 21. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
    De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
    Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial.
    Tversky J; Lane AP; Azar A
    Clin Exp Allergy; 2021 Jun; 51(6):836-844. PubMed ID: 33595845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.
    Dharmarajan H; Falade O; Lee SE; Wang EW
    Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps.
    Hopkins C; Wagenmann M; Bachert C; Desrosiers M; Han JK; Hellings PW; Lee SE; Msihid J; Radwan A; Rowe P; Amin N; Deniz Y; Ortiz B; Mannent LP; Rout R
    Int Forum Allergy Rhinol; 2021 Jul; 11(7):1087-1101. PubMed ID: 33611847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report.
    Orlando P; Licci G; Kuitche D; Matucci A; Vultaggio A; Gallo O; Maggiore G
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1317-1324. PubMed ID: 37910208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening olfaction under dupilumab in chronic rhinosinusitis with nasal polyps.
    Mauthe T; Meerwein CM; Ryser FS; Brà Hlmann C; Yalamanoglu A; Steiner UC; Soyka MB
    Rhinology; 2024 Aug; 62(4):496-505. PubMed ID: 38949841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies.
    Lee SE; Hopkins C; Mullol J; Msihid J; Guillemin I; Amin N; Mannent LP; Li Y; Siddiqui S; Chuang CC; Kamat S; Khan AH
    Allergy; 2022 Jul; 77(7):2211-2221. PubMed ID: 35034364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologics for chronic rhinosinusitis with nasal polyps.
    Bachert C; Zhang N; Cavaliere C; Weiping W; Gevaert E; Krysko O
    J Allergy Clin Immunol; 2020 Mar; 145(3):725-739. PubMed ID: 32145872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.
    Weinstein SF; Katial RK; Bardin P; Korn S; McDonald M; Garin M; Bateman ED; Hoyte FCL; Germinaro M
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):589-596.e3. PubMed ID: 30193936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative real-world outcomes of dupilumab versus endoscopic sinus surgery in the treatment of severe CRSwNP patients.
    De Corso E; Porru DP; Corbò M; Montuori C; De Maio G; Mastrapasqua RF; Panfili M; Spanu C; Di Bella GA; D'Agostino G; Rizzuti A; Passali GC; Galli J
    Clin Otolaryngol; 2024 Jul; 49(4):481-489. PubMed ID: 38711363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis.
    Fokkens W; Van Der Lans R; Reitsma S
    Expert Opin Biol Ther; 2021 May; 21(5):575-585. PubMed ID: 33724109
    [No Abstract]   [Full Text] [Related]  

  • 32. Dupilumab improves sleep quality in chronic rhinosinusitis with nasal polyps.
    Riva G; Garetto M; Borgione M; Piazza F; Prizio C; Dellea D; Albera A; Canale A; Pecorari G
    Am J Otolaryngol; 2024; 45(4):104310. PubMed ID: 38677148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis.
    Boyle JV; Lam K; Han JK
    Immunotherapy; 2020 Feb; 12(2):111-121. PubMed ID: 32075470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential nasal swab cytology represents a valuable tool for therapy monitoring but not prediction of therapy response in chronic rhinosinusitis with nasal polyps treated with Dupilumab.
    Danisman Z; Linxweiler M; Kühn JP; Linxweiler B; Solomayer EF; Wagner M; Wagenpfeil G; Schick B; Berndt S
    Front Immunol; 2023; 14():1127576. PubMed ID: 37180133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjunctivitis in dupilumab clinical trials.
    Akinlade B; Guttman-Yassky E; de Bruin-Weller M; Simpson EL; Blauvelt A; Cork MJ; Prens E; Asbell P; Akpek E; Corren J; Bachert C; Hirano I; Weyne J; Korotzer A; Chen Z; Hultsch T; Zhu X; Davis JD; Mannent L; Hamilton JD; Teper A; Staudinger H; Rizova E; Pirozzi G; Graham NMH; Shumel B; Ardeleanu M; Wollenberg A
    Br J Dermatol; 2019 Sep; 181(3):459-473. PubMed ID: 30851191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review.
    Nitro L; Bulfamante AM; Rosso C; Saibene AM; Arnone F; Felisati G; Pipolo C
    Acta Otorhinolaryngol Ital; 2022 Jun; 42(3):199-204. PubMed ID: 35880360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS-24 and SINUS-52 trials.
    Bachert C; Corren J; Lee SE; Zhang H; Harel S; Cunoosamy D; Khan AH; Jacob-Nara JA; Siddiqui S; Nash S; Rowe PJ; Deniz Y
    Int Forum Allergy Rhinol; 2022 Sep; 12(9):1191-1195. PubMed ID: 34970860
    [No Abstract]   [Full Text] [Related]  

  • 38. Very Rapid Improvement in Extended Nitric Oxide Parameters Is Associated With Clinical and Functional Improvement in Patients With Chronic Rhinosinusitis With Nasal Polyps Treated With Dupilumab.
    Paoletti G; Casini M; Malvezzi L; Pirola F; Russo E; Nappi E; Muci GQ; Montagna C; Messina MR; Ferri S; Racca F; Lamacchia D; Cataldo G; Puggioni F; De Virgilio A; Ferreli F; Mercante G; Spriano G; Canonica GW; Heffler E
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):457-463. PubMed ID: 38095494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-World Adverse Events After Type 2 Biologic use in Chronic Rhinosinusitis with Nasal Polyps.
    Dorling M; Hernaiz-Leonardo JC; Pascual A; Janjua A; Thamboo A; Javer A
    Laryngoscope; 2024 Jul; 134(7):3054-3059. PubMed ID: 38314858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.